Skip to main content

Allergy Program News

Experts from CHOP’s Allergy Program are recognized as global leaders in the management of allergic conditions and have helped formulate many of the national guidelines used by physicians around the world.

Contact us

Reduced Inhaler Use is Safe for Infants with Bronchiolitis

Jan 13, 2020

Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients. A multidisciplinary team of researchers from Children’s Hospital of Philadelphia (CHOP) redesigned the hospital’s standard treatment for the infection and reduced albuterol use without compromising care.

Jump back to top